Recombinant Human Anti-CCR5 x Human Anti-CD3 Bispecific Antibody (Fv-IgG)  (BSDG-H206)

Recombinant Anti-CCR5 x Anti-CD3 Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-CCR5 IgG with similar domains from an anti-CD3 antibody via short peptide linkers, or vice versa. This BsAb can retarget T cells to CCR5 target cells. It is designed for the research of HIV-1 infection, AIDS therapy.

Datasheet